Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 3.271
Filtrer
1.
Physiol Rep ; 12(12): e16090, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38884325

RÉSUMÉ

Adverse effects of large artery stiffening are well established in the systemic circulation; stiffening of the proximal pulmonary artery (PPA) and its sequelae are poorly understood. We combined in vivo (n = 6) with ex vivo data from cadavers (n = 8) and organ donors (n = 13), ages 18 to 89, to assess whether aging of the PPA associates with changes in distensibility, biaxial wall strain, wall thickness, vessel diameter, and wall composition. Aging exhibited significant negative associations with distensibility and cyclic biaxial strain of the PPA (p ≤ 0.05), with decreasing circumferential and axial strains of 20% and 7%, respectively, for every 10 years after 50. Distensibility associated directly with diffusion capacity of the lung (R2 = 0.71, p = 0.03). Axial strain associated with right ventricular ejection fraction (R2 = 0.76, p = 0.02). Aging positively associated with length of the PPA (p = 0.004) and increased luminal caliber (p = 0.05) but showed no significant association with mean wall thickness (1.19 mm, p = 0.61) and no significant differences in the proportions of mural elastin and collagen (p = 0.19) between younger (<50 years) and older (>50) ex vivo samples. We conclude that age-related stiffening of the PPA differs from that of the aorta; microstructural remodeling, rather than changes in overall geometry, may explain age-related stiffening.


Sujet(s)
Vieillissement , Artère pulmonaire , Rigidité vasculaire , Humains , Artère pulmonaire/physiologie , Sujet âgé , Mâle , Femelle , Adulte d'âge moyen , Adulte , Vieillissement/physiologie , Sujet âgé de 80 ans ou plus , Adolescent , Rigidité vasculaire/physiologie , Jeune adulte , Élastine/métabolisme
2.
Arch Dermatol Res ; 316(7): 428, 2024 Jun 21.
Article de Anglais | MEDLINE | ID: mdl-38904694

RÉSUMÉ

Cannabidiol (CBD), which is derived from hemp, is gaining recognition because of its anti-inflammatory and lipid-modulating properties that could be utilized to treat acne. We conducted experiments to quantitatively assess the effects of CBD on acne-related cellular pathways. SEB-1 sebocytes and HaCaT keratinocytes were exposed to various CBD concentrations. CBD exhibited a concentration-dependent impact on cell viability and notably reduced SEB-1 viability; furthermore, it induced apoptosis and a significant increase in the apoptotic area at higher concentrations. Additionally, CBD remarkably reduced pro-inflammatory cytokines, including CXCL8, IL-1α, and IL-1ß. Additionally, it inhibited lipid synthesis by modulating the AMPK-SREBP-1 pathway and effectively reduced hyperkeratinization-related protein keratin 16. Simultaneously, CBD stimulated the synthesis of elastin, collagen 1, and collagen 3. These findings emphasize the potential of CBD for the management of acne because of its anti-inflammatory, apoptotic, and lipid-inhibitory effects. Notably, the modulation of the Akt/AMPK-SREBP-1 pathway revealed a novel and promising mechanism that could address the pathogenesis of acne.


Sujet(s)
Acné juvénile , Apoptose , Cannabidiol , Survie cellulaire , Kératinocytes , Transduction du signal , Humains , Acné juvénile/traitement médicamenteux , Cannabidiol/pharmacologie , Cannabidiol/usage thérapeutique , Apoptose/effets des médicaments et des substances chimiques , Kératinocytes/effets des médicaments et des substances chimiques , Kératinocytes/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Cicatrice/traitement médicamenteux , Cicatrice/anatomopathologie , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Protéine-1 de liaison à l'élément de régulation des stérols/métabolisme , Cellules HaCaT , AMP-Activated Protein Kinases/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Collagène de type I/métabolisme , Collagène de type I/génétique , Collagène de type III/métabolisme , Élastine/métabolisme , Glandes sébacées/anatomopathologie , Glandes sébacées/effets des médicaments et des substances chimiques , Glandes sébacées/métabolisme , Interleukine-1 alpha/métabolisme , Interleukine-1 bêta/métabolisme , Interleukine-8/métabolisme , Lignée cellulaire
3.
Int J Mol Sci ; 25(11)2024 May 27.
Article de Anglais | MEDLINE | ID: mdl-38891996

RÉSUMÉ

Human abdominal aortic aneurysms (AAAs) are characterized by increased activity of matrix metalloproteinases (MMP), including MMP-12, alongside macrophage accumulation and elastin degradation, in conjunction with superimposed atherosclerosis. Previous genetic ablation studies have proposed contradictory roles for MMP-12 in AAA development. In this study, we aimed to elucidate if pharmacological inhibition of MMP-12 activity with a phosphinic peptide inhibitor protects from AAA formation and progression in angiotensin (Ang) II-infused Apoe-/- mice. Complimentary studies were conducted in a human ex vivo model of early aneurysm development. Administration of an MMP-12 inhibitor (RXP470.1) protected hypercholesterolemia Apoe-/- mice from Ang II-induced AAA formation and rupture-related death, associated with diminished medial thinning and elastin fragmentation alongside increased collagen deposition. Proteomic analyses confirmed a beneficial effect of MMP-12 inhibition on extracellular matrix remodeling proteins combined with inflammatory pathways. Furthermore, RXP470.1 treatment of mice with pre-existing AAAs exerted beneficial effects as observed through suppressed aortic dilation and rupture, medial thinning, and elastin destruction. Our findings indicate that pharmacological inhibition of MMP-12 activity retards AAA progression and improves survival in mice providing proof-of-concept evidence to motivate translational work for MMP-12 inhibitor therapy in humans.


Sujet(s)
Angiotensine-II , Anévrysme de l'aorte abdominale , Apolipoprotéines E , Matrix metalloproteinase 12 , Inhibiteurs de métalloprotéinases matricielles , Animaux , Anévrysme de l'aorte abdominale/métabolisme , Anévrysme de l'aorte abdominale/anatomopathologie , Anévrysme de l'aorte abdominale/induit chimiquement , Anévrysme de l'aorte abdominale/prévention et contrôle , Anévrysme de l'aorte abdominale/étiologie , Matrix metalloproteinase 12/métabolisme , Souris , Apolipoprotéines E/déficit , Apolipoprotéines E/génétique , Humains , Inhibiteurs de métalloprotéinases matricielles/pharmacologie , Inhibiteurs de métalloprotéinases matricielles/usage thérapeutique , Mâle , Modèles animaux de maladie humaine , Souris knockout , Souris de lignée C57BL , Élastine/métabolisme , Protéomique/méthodes
4.
Arterioscler Thromb Vasc Biol ; 44(7): 1674-1682, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38752350

RÉSUMÉ

BACKGROUND: A series of incurable cardiovascular disorders arise due to improper formation of elastin during development. Supravalvular aortic stenosis (SVAS), resulting from a haploinsufficiency of ELN, is caused by improper stress sensing by medial vascular smooth muscle cells, leading to progressive luminal occlusion and heart failure. SVAS remains incurable, as current therapies do not address the root issue of defective elastin. METHODS: We use SVAS here as a model of vascular proliferative disease using both human induced pluripotent stem cell-derived vascular smooth muscle cells and developmental Eln+/- mouse models to establish de novo elastin assembly as a new therapeutic intervention. RESULTS: We demonstrate mitigation of vascular proliferative abnormalities following de novo extracellular elastin assembly through the addition of the polyphenol epigallocatechin gallate to SVAS human induced pluripotent stem cell-derived vascular smooth muscle cells and in utero to Eln+/- mice. CONCLUSIONS: We demonstrate de novo elastin deposition normalizes SVAS human induced pluripotent stem cell-derived vascular smooth muscle cell hyperproliferation and rescues hypertension and aortic mechanics in Eln+/- mice, providing critical preclinical findings for the future application of epigallocatechin gallate treatment in humans.


Sujet(s)
Rétrécissement aortique supravalvulaire , Catéchine , Prolifération cellulaire , Modèles animaux de maladie humaine , Élastine , Cellules souches pluripotentes induites , Muscles lisses vasculaires , Myocytes du muscle lisse , Élastine/métabolisme , Animaux , Humains , Catéchine/analogues et dérivés , Catéchine/pharmacologie , Myocytes du muscle lisse/métabolisme , Myocytes du muscle lisse/anatomopathologie , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Rétrécissement aortique supravalvulaire/métabolisme , Rétrécissement aortique supravalvulaire/génétique , Muscles lisses vasculaires/métabolisme , Muscles lisses vasculaires/anatomopathologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cellules souches pluripotentes induites/métabolisme , Cellules souches pluripotentes induites/effets des médicaments et des substances chimiques , Souris , Cellules cultivées , Souris de lignée C57BL , Femelle , Mâle , Souris knockout
5.
J Immunol ; 213(1): 75-85, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38758115

RÉSUMÉ

In chronic obstructive pulmonary disease (COPD), inflammation gives rise to protease-mediated degradation of the key extracellular matrix protein, elastin, which causes irreversible loss of pulmonary function. Intervention against proteolysis has met with limited success in COPD, due in part to our incomplete understanding of the mechanisms that underlie disease pathogenesis. Peptidyl arginine deiminase (PAD) enzymes are a known modifier of proteolytic susceptibility, but their involvement in COPD in the lungs of affected individuals is underexplored. In this study, we showed that enzyme isotypes PAD2 and PAD4 are present in primary granules of neutrophils and that cells from people with COPD release increased levels of PADs when compared with neutrophils of healthy control subjects. By examining bronchoalveolar lavage and lung tissue samples of patients with COPD or matched smoking and nonsmoking counterparts with normal lung function, we reveal that COPD presents with markedly increased airway concentrations of PADs. Ex vivo, we established citrullinated elastin in the peripheral airways of people with COPD, and in vitro, elastin citrullination significantly enhanced its proteolytic degradation by serine and matrix metalloproteinases, including neutrophil elastase and matrix metalloprotease-12, respectively. These results provide a mechanism by which neutrophil-released PADs affect lung function decline, indicating promise for the future development of PAD-based therapeutics for preserving lung function in patients with COPD.


Sujet(s)
Élastine , Granulocytes neutrophiles , Protein-arginine deiminase Type 2 , Protein-arginine deiminase Type 4 , Protéolyse , Broncho-pneumopathie chronique obstructive , Emphysème pulmonaire , Humains , Granulocytes neutrophiles/immunologie , Élastine/métabolisme , Femelle , Mâle , Protein-arginine deiminase Type 4/métabolisme , Adulte d'âge moyen , Emphysème pulmonaire/métabolisme , Emphysème pulmonaire/anatomopathologie , Emphysème pulmonaire/immunologie , Sujet âgé , Protein-arginine deiminase Type 2/métabolisme , Broncho-pneumopathie chronique obstructive/métabolisme , Citrullination , Protein-arginine deiminases/métabolisme , Leukocyte elastase/métabolisme , Poumon/immunologie , Poumon/anatomopathologie
6.
J Cosmet Dermatol ; 23(7): 2401-2410, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38778550

RÉSUMÉ

BACKGROUND: The negative effects of skin aging are primarily related to the destruction of dermal architectural structure. More specifically, this includes changes in the spatial arrangement of collagen, elastin fibers, mucopolysaccharides, proteoglycans, and ground substances. AIMS: The purpose of this study is to investigate the histologic effects of dermal and subdermal tissue after a controlled single treatment with radiofrequency (RF) macroneedling. This therapy provides a controlled, localized, thermal effect on the dermis whereby triggering the body's own healing processes of extracellular matrix remodeling. Clinically benefits include skin tightening. METHODS: Biopsies were obtained for histologic evaluation from four patients (n = 4), 4 weeks after completing a single RF macroneedling facial treatment. RESULTS: Age-related changes of the dermal and subdermal architecture were observed at baseline. After treatment, all biopsies demonstrated an increase in epidermal cells, collagen, elastin, fibroblasts, vasculature, and a decrease in inflammatory cells. CONCLUSIONS: The results of this histologic study confirm a significant "subsurfacing" thermal effect from the noncoagulative ascendant thermal injury. The obtained results characterize RF macroneedling therapy as an effective method for correcting age-related changes in facial skin.


Sujet(s)
Traitement par radiofréquence , Vieillissement de la peau , Humains , Vieillissement de la peau/effets des radiations , Femelle , Adulte d'âge moyen , Traitement par radiofréquence/méthodes , Traitement par radiofréquence/effets indésirables , Traitement par radiofréquence/instrumentation , Derme/effets des radiations , Derme/anatomopathologie , Biopsie , Élastine/métabolisme , Élastine/analyse , Face , Adulte , Sujet âgé , Collagène/métabolisme , Fibroblastes/effets des radiations , Mâle , Peau/effets des radiations , Peau/anatomopathologie , Techniques cosmétiques/effets indésirables , Techniques cosmétiques/instrumentation , Résultat thérapeutique
7.
ACS Appl Bio Mater ; 7(6): 3714-3720, 2024 Jun 17.
Article de Anglais | MEDLINE | ID: mdl-38748757

RÉSUMÉ

Biological water-responsive (WR) materials are abundant in nature, and they are used as mechanical actuators for seed dispersal by many plants such as wheat awns and pinecones. WR biomaterials are of interest for applications as high-energy actuators, which can be useful in soft robotics or for capturing energy from natural water evaporation. Recent work on WR silk proteins has shown that ß-sheet nanocrystalline domains with high stiffness correlate with the high WR actuation energy density, but the fundamental mechanisms to drive water responsiveness in proteins remain poorly understood. Here, we design, synthesize, and study protein block copolymers consisting of two α-helical domains derived from cartilage oligomeric matrix protein coiled-coil (C) flanking an elastin-like peptide domain (E), namely, CEC. We use these protein materials to create WR actuators with energy densities that outperform mammalian muscle. To elucidate the effect of structure on WR actuation, CEC was compared to a variant, CECL44A, in which a point mutation disrupts the α-helical structure of the C domain. Surprisingly, CECL44A outperformed CEC, showing higher energy density and less susceptibility to degradation after repeated cycling. We show that CECL44A exhibits a higher degree of intermolecular interactions and is stiffer than CEC at high relative humidity (RH), allowing for less energy dissipation during water responsiveness. These results suggest that strong intermolecular interactions and the resulting, relatively steady protein structure are important for water responsiveness.


Sujet(s)
Matériaux biocompatibles , Test de matériaux , Eau , Eau/composition chimique , Matériaux biocompatibles/composition chimique , Polymères/composition chimique , Taille de particule , Protéine oligomérique de la matrice du cartilage/composition chimique , Protéine oligomérique de la matrice du cartilage/métabolisme , Élastine/composition chimique , Élastine/métabolisme
8.
J Mech Behav Biomed Mater ; 156: 106597, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38810542

RÉSUMÉ

The skin, the outermost organ of the human body, is vital for sensing and responding to stimuli through mechanotransduction. It is constantly exposed to mechanical stress. Consequently, various mechanical therapies, including compression, massage, and microneedling, have become routine practices for skin healing and regeneration. However, these traditional methods require direct skin contact, restricting their applicability. To address this constraint, we developed shear wave stimulation (SWS), a contactless mechanical stimulation technique. The effectiveness of SWS was compared with that of a commercial compression bioreactor used on reconstructed skin at various stages of maturity. Despite the distinct stimulus conditions applied by the two methods, SWS yielded remarkable outcomes, similar to the effects of the compression bioreactor. It significantly increased the shear modulus of tissue-engineered skin, heightened the density of collagen and elastin fibers, and resulted in an augmentation of fibroblasts in terms of their number and length. Notably, SWS exhibited diverse effects in the low- and high-frequency modes, highlighting the importance of fine-tuning the stimulus intensity. These results unequivocally demonstrated the capability of SWS to enhance the mechanical functions of the skin in vitro, making it a promising option for addressing wound healing and stretch mark recovery.


Sujet(s)
Peau , Peau/cytologie , Humains , Contrainte mécanique , Ingénierie tissulaire , Phénomènes mécaniques , Phénomènes biomécaniques , Fibroblastes/cytologie , Animaux , Collagène , Résistance au cisaillement , Élastine/métabolisme
9.
Am J Physiol Lung Cell Mol Physiol ; 326(6): L812-L820, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38712445

RÉSUMÉ

Chronic obstructive pulmonary disease (COPD) is a condition characterized by chronic airway inflammation and obstruction, primarily caused by tobacco smoking. Although the involvement of immune cells in COPD pathogenesis is well established, the contribution of innate lymphoid cells (ILCs) remains poorly understood. ILCs are a type of innate immune cells that participate in tissue remodeling processes, but their specific role in COPD has not been fully elucidated. During COPD, the breakdown of pulmonary elastin generates elastin peptides that elicit biological activities on immune cells. This study aimed to investigate the presence of ILC in patients with COPD and examine the impact of elastin peptides on their functionality. Our findings revealed an elevated proportion of ILC2 in the peripheral blood of patients with COPD, and a general activation of ILC as indicated by an increase in their cytokine secretion capacity. Notably, our study demonstrated that serum from patients with COPD promotes ILC2 phenotype, likely due to the elevated concentration of IL-5, a cytokine known to favor ILC2 activation. Furthermore, we uncovered that this increase in IL-5 secretion is partially attributed to its secretion by macrophages upon stimulation by elastin peptides, suggesting an indirect role of elastin peptides on ILC in COPD. These findings shed light on the involvement of ILC in COPD and provide insights into the potential interplay between elastin breakdown, immune cells, and disease progression. Further understanding of the mechanisms underlying ILC activation and their interaction with elastin peptides could contribute to the development of novel therapeutic strategies for COPD management.NEW & NOTEWORTHY Elastin-derived peptides, generated following alveolar degradation during emphysema in patients with COPD, are able to influence the response of type 2 innate lymphoid cells. We show that the orientation of innate lymphoid cells in patients with COPD is shifted toward a type 2 profile and that elastin peptides are indirectly participating in that shift through their influence of macrophages, which in turn impact innate lymphoid cells.


Sujet(s)
Élastine , Immunité innée , Lymphocytes , Broncho-pneumopathie chronique obstructive , Humains , Broncho-pneumopathie chronique obstructive/immunologie , Broncho-pneumopathie chronique obstructive/anatomopathologie , Élastine/métabolisme , Élastine/immunologie , Lymphocytes/immunologie , Lymphocytes/métabolisme , Lymphocytes/effets des médicaments et des substances chimiques , Femelle , Mâle , Sujet âgé , Adulte d'âge moyen , Interleukine-5/métabolisme , Interleukine-5/immunologie , Macrophages/immunologie , Macrophages/métabolisme , Peptides/pharmacologie , Peptides/immunologie
10.
Commun Biol ; 7(1): 577, 2024 May 16.
Article de Anglais | MEDLINE | ID: mdl-38755434

RÉSUMÉ

Pseudoxanthoma elasticum (PXE) is a rare disease characterized by ectopic calcification, however, despite the widely spread effect of pro/anti-calcifying systemic factors associated with this genetic metabolic condition, it is not known why elastic fibers in the same patient are mainly fragmented or highly mineralized in clinically unaffected (CUS) and affected (CAS) skin, respectively. Cellular morphology and secretome are investigated in vitro in CUS and CAS fibroblasts. Here we show that, compared to CUS, CAS fibroblasts exhibit: a) differently distributed and organized focal adhesions and stress fibers; b) modified cell-matrix interactions (i.e., collagen gel retraction); c) imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases; d) differentially expressed pro- and anti-calcifying proteoglycans and elastic-fibers associated glycoproteins. These data emphasize that in the development of pathologic mineral deposition fibroblasts play an active role altering the stability of elastic fibers and of the extracellular matrix milieu creating a local microenvironment guiding the level of matrix remodeling at an extent that may lead to degradation (in CUS) or to degradation and calcification (in CAS) of the elastic component. In conclusion, this study contributes to a better understanding of the mechanisms of the mineral deposition that can be also associated with several inherited or age-related diseases (e.g., diabetes, atherosclerosis, chronic kidney diseases).


Sujet(s)
Calcinose , Élastine , Fibroblastes , Pseudoxanthome élastique , Pseudoxanthome élastique/métabolisme , Pseudoxanthome élastique/anatomopathologie , Pseudoxanthome élastique/génétique , Humains , Élastine/métabolisme , Fibroblastes/métabolisme , Fibroblastes/anatomopathologie , Calcinose/métabolisme , Calcinose/anatomopathologie , Derme/métabolisme , Derme/anatomopathologie , Adulte d'âge moyen , Femelle , Mâle , Adulte , Cellules cultivées , Matrice extracellulaire/métabolisme , Tissu élastique/métabolisme , Tissu élastique/anatomopathologie
11.
Sci Rep ; 14(1): 10253, 2024 05 04.
Article de Anglais | MEDLINE | ID: mdl-38704431

RÉSUMÉ

The tegument protein pp150 of Human Cytomegalovirus (HCMV) is known to be essential for the final stages of virus maturation and mediates its functions by interacting with capsid proteins. Our laboratory has previously identified the critical regions in pp150 important for pp150-capsid interactions and designed peptides similar in sequence to these regions, with a goal to competitively inhibit capsid maturation. Treatment with a specific peptide (PepCR2 or P10) targeted to pp150 conserved region 2 led to a significant reduction in murine CMV (MCMV) growth in cell culture, paving the way for in vivo testing in a mouse model of CMV infection. However, the general pharmacokinetic parameters of peptides, including rapid degradation and limited tissue and cell membrane permeability, pose a challenge to their successful use in vivo. Therefore, we designed a biopolymer-stabilized elastin-like polypeptide (ELP) fusion construct (ELP-P10) to enhance the bioavailability of P10. Antiviral efficacy and cytotoxic effects of ELP-P10 were studied in cell culture, and pharmacokinetics, biodistribution, and antiviral efficacy were studied in a mouse model of CMV infection. ELP-P10 maintained significant antiviral activity in cell culture, and this conjugation significantly enhanced P10 bioavailability in mouse tissues. The fluorescently labeled ELP-P10 accumulated to higher levels in mouse liver and kidneys as compared to the unconjugated P10. Moreover, viral titers from vital organs of MCMV-infected mice indicated a significant reduction of virus load upon ELP-P10 treatment. Therefore, ELP-P10 has the potential to be developed into an effective antiviral against CMV infection.


Sujet(s)
Antiviraux , Infections à cytomégalovirus , Élastine , Muromegalovirus , Peptides , Phosphoprotéines , Protéines de la matrice virale , Animaux , Élastine/composition chimique , Élastine/métabolisme , Infections à cytomégalovirus/traitement médicamenteux , Infections à cytomégalovirus/virologie , Souris , Antiviraux/pharmacologie , Antiviraux/pharmacocinétique , Antiviraux/composition chimique , Peptides/pharmacologie , Peptides/composition chimique , Muromegalovirus/effets des médicaments et des substances chimiques , Humains , Protéines de capside/métabolisme , Protéines de capside/composition chimique , Cytomegalovirus/effets des médicaments et des substances chimiques , Capside/métabolisme , Capside/effets des médicaments et des substances chimiques , Protéines de fusion recombinantes/pharmacologie , Protéines de fusion recombinantes/pharmacocinétique , Modèles animaux de maladie humaine ,
12.
J Mater Chem B ; 12(19): 4698-4707, 2024 May 15.
Article de Anglais | MEDLINE | ID: mdl-38652007

RÉSUMÉ

This paper explores the use of a di-cationic fluorophore for visualizing mitochondria in live cells independent of membrane potential. Through the synthesized di-cationic fluorophore, we investigate the monitoring of viscosity, ferroptosis, stress-induced mitophagy, and lysosomal uptake of damaged mitochondria. The designed fluorophore is based on DQAsomes, cationic vesicles responsible for transporting drugs and DNA to mitochondria. The symmetric fluorophores possess two charge centres separated by an alkyl chain and are distinguished by a pyridinium group for mitochondrial selectivity, the C-12 alkyl substitution for membrane affinity, and an electron donor-π-acceptor fluorescent scaffold for intramolecular charge transfer. The synthesized fluorophores, PP and NP, emit wavelengths exceeding 600 nm, with a significant Stokes shift (130-211 nm), and NP demonstrates near-infrared emission (∼690 nm). Our study underscores the potential of these fluorophores for live-cell imaging, examining physiological responses such as viscosity and ferroptosis, and highlights their utility in investigating mitophagy damage and lysosomal uptake.


Sujet(s)
Ferroptose , Mitochondries , Mitophagie , Mitochondries/composition chimique , Mitochondries/métabolisme , Spectroscopie proche infrarouge , Animaux , Cellules COS , Chlorocebus aethiops , Viscosité , Survie cellulaire , Élastine/génétique , Élastine/métabolisme
14.
Hypertension ; 81(6): 1308-1319, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38563153

RÉSUMÉ

BACKGROUND: Abnormalities of resistance arteries may play essential roles in the pathophysiology of aging and hypertension. Deficiency of the vascular extracellular matrix protein MFAP4 (microfibrillar-associated protein 4) has previously been observed as protective against aberrant arterial remodeling. We hypothesized that MFAP4-deficiency would reduce age- and hypertension-dependent arterial changes in extracellular matrix composition and stiffening. METHODS: Mesenteric arteries were isolated from old (20-23 months) littermate Mfap4+/+ and Mfap4-/- mice, and 2-photon excitation microscopy imaging was used to quantify elastin and collagen volumes and dimensions in the vascular wall. Ten-week-old littermate Mfap4+/+ and Mfap4-/- mice were subjected to 20 days of continuous Ang II (angiotensin II) infusion and hypertension was monitored using invasive blood pressure measurements. Arterial stiffness, responses to vascular constrictors, and myogenic tone were monitored using wire- or pressure-myography. Collagen contents were assessed by Western blotting. RESULTS: MFAP4-deficiency significantly increased collagen volume and elastin fragmentation in aged mesenteric arteries without affecting arterial stiffness. MFAP4-deficient mice exhibited reduced diastolic pressure in Ang II-induced hypertension. There was no significant effect of MFAP4-deficiency on mesenteric artery structural remodeling or myogenic tone, although collagen content in mesenteric arteries was tendentially increased in hypertensive Mfap4+/+ mice relative to Mfap4-/- mice. Increased efficacy of vasoconstrictors (phenylephrine, thromboxane) and reduced stiffness were observed in Ang II-treated Mfap4-/- mouse mesenteric arteries in ex vivo myography recordings. CONCLUSIONS: MFAP4-deficiency reduces the elastin/collagen ratio in the aging resistance artery without affecting arterial stiffness. In contrast, MFAP4-deficiency reduces the stiffness of resistance arteries and ameliorates Ang II-induced hypertension.


Sujet(s)
Vieillissement , Angiotensine-II , Hypertension artérielle , Artères mésentériques , Résistance vasculaire , Rigidité vasculaire , Animaux , Hypertension artérielle/physiopathologie , Hypertension artérielle/métabolisme , Hypertension artérielle/génétique , Souris , Artères mésentériques/physiopathologie , Artères mésentériques/effets des médicaments et des substances chimiques , Artères mésentériques/métabolisme , Rigidité vasculaire/physiologie , Rigidité vasculaire/effets des médicaments et des substances chimiques , Résistance vasculaire/physiologie , Vieillissement/physiologie , Angiotensine-II/pharmacologie , Élastine/métabolisme , Pression sanguine/physiologie , Protéines de la matrice extracellulaire/métabolisme , Protéines de la matrice extracellulaire/génétique , Protéines de la matrice extracellulaire/déficit , Souris knockout , Modèles animaux de maladie humaine , Mâle , Collagène/métabolisme
15.
Int Angiol ; 43(2): 229-239, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38619205

RÉSUMÉ

BACKGROUND: Varicose veins affect approximately 25% of people in industrialized countries. METHODS: The study aimed at detecting apoptotic cells and histopathological changes in varicose vein walls. Patients (N.=41) with varicose veins and 30 control group patients were divided into two groups according to their age (younger and older than 50 years). Apoptosis was determined by the TUNEL assay, elastin and collagen IV expression by immunohistochemistry and ultrastructural changes by transmission electron microscopy. RESULTS: The results show that the number of apoptotic cells in the layers of varicose veins increased, in particular in a group of patients aged over 50 years. In the varicose veins as compared to control veins the elastic fibers were found to be thinner, more fragmented and disorderly arranged. Elastin and collagen IV expression was found to decline in the intima and the media of varicose veins in both age groups. Electron microscopy demonstrated hypertrophy and degeneration of smooth muscle cells. Furthermore, cells with ultrastructural feature of apoptosis were noted. In the disorganized and expanded extracellular matrix membrane-bound vesicles, ghost bodies with different size and electron density were observed. Ghost bodies seem to bud off from smooth muscle cells and are likely to be involved in extracellular matrix remodeling as they are seen in close contact with collagen fibers. CONCLUSIONS: The study demonstrates increase of apoptotic cells in the wall of varicose veins along with vein wall structural abnormalities including alterations of smooth muscle cells and decline of elastin and collagen IV expression.


Sujet(s)
Apoptose , Élastine , Microscopie électronique à transmission , Myocytes du muscle lisse , Veine saphène , Varices , Humains , Veine saphène/ultrastructure , Veine saphène/anatomopathologie , Veine saphène/métabolisme , Adulte d'âge moyen , Élastine/métabolisme , Varices/anatomopathologie , Varices/métabolisme , Femelle , Adulte , Mâle , Myocytes du muscle lisse/ultrastructure , Myocytes du muscle lisse/anatomopathologie , Myocytes du muscle lisse/métabolisme , Sujet âgé , Études cas-témoins , Collagène de type IV/métabolisme , Muscles lisses vasculaires/ultrastructure , Muscles lisses vasculaires/anatomopathologie , Muscles lisses vasculaires/métabolisme , Immunohistochimie , Insuffisance veineuse/anatomopathologie , Insuffisance veineuse/métabolisme , Jeune adulte , Facteurs âges , Tissu élastique/ultrastructure , Tissu élastique/métabolisme , Tissu élastique/anatomopathologie
16.
Transgenic Res ; 33(1-2): 21-33, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38573429

RÉSUMÉ

Plants can produce complex pharmaceutical and technical proteins. Spider silk proteins are one example of the latter and can be used, for example, as compounds for high-performance textiles or wound dressings. If genetically fused to elastin-like polypeptides (ELPs), the silk proteins can be reversibly precipitated from clarified plant extracts at moderate temperatures of ~ 30 °C together with salt concentrations > 1.5 M, which simplifies purification and thus reduces costs. However, the technologies developed around this mechanism rely on a repeated cycling between soluble and aggregated state to remove plant host cell impurities, which increase process time and buffer consumption. Additionally, ELPs are difficult to detect using conventional staining methods, which hinders the analysis of unit operation performance and process development. Here, we have first developed a surface plasmon resonance (SPR) spectroscopy-based assay to quantity ELP fusion proteins. Then we tested different filters to prepare clarified plant extract with > 50% recovery of spider silk ELP fusion proteins. Finally, we established a membrane-based purification method that does not require cycling between soluble and aggregated ELP state but operates similar to an ultrafiltration/diafiltration device. Using a data-driven design of experiments (DoE) approach to characterize the system of reversible ELP precipitation we found that membranes with pore sizes up to 1.2 µm and concentrations of 2-3 M sodium chloride facilitate step a recovery close to 100% and purities of > 90%. The system can thus be useful for the purification of ELP-tagged proteins produced in plants and other hosts.


Sujet(s)
, Soie , Soie/génétique , Protéines d'arthropode , Élastine/génétique , Élastine/composition chimique , Élastine/métabolisme , Nicotiana/génétique , Protéines de fusion recombinantes/génétique
17.
J Med Chem ; 67(8): 6624-6637, 2024 Apr 25.
Article de Anglais | MEDLINE | ID: mdl-38588467

RÉSUMÉ

The increased remodeling of the extracellular matrix (ECM) in pulmonary fibrosis (PF) generates bioactive ECM fragments called matricryptins, which include elastin-derived peptides (EDPs). The interaction between EDPs and their receptors, including elastin-binding protein (EBP), plays a crucial role in exacerbating fibrosis. Here, we present LXJ-02 for the first time, a novel ultralong-acting inhibitor that disrupts the EDPs/EBP peptide-protein interaction, promoting macrophages to secrete matrix metalloproteinase-12 (MMP-12), and showing great promise as a stable peptide. MMP-12 has traditionally been implicated in promoting inflammation and fibrosis in various acute and chronic diseases. However, we reveal a novel role of LXJ-02 that activates the macrophage-MMP-12 axis to increase MMP-12 expression and degrade ECM components like elastin. This leads to the preventing of PF while also improving EDP-EBP interaction. LXJ-02 effectively reverses PF in mouse models with minimal side effects, holding great promise as an excellent therapeutic agent for lung fibrosis.


Sujet(s)
Conception de médicament , Élastine , Fibrose pulmonaire , Récepteurs de surface cellulaire , Fibrose pulmonaire/traitement médicamenteux , Fibrose pulmonaire/anatomopathologie , Fibrose pulmonaire/métabolisme , Animaux , Souris , Élastine/composition chimique , Élastine/métabolisme , Humains , Matrix metalloproteinase 12/métabolisme , Peptides/pharmacologie , Peptides/composition chimique , Peptides/synthèse chimique , Souris de lignée C57BL , Macrophages/effets des médicaments et des substances chimiques , Macrophages/métabolisme , Mâle
18.
Adv Sci (Weinh) ; 11(24): e2301708, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38477407

RÉSUMÉ

While direct cell transplantation holds great promise in treating many debilitating diseases, poor cell survival and engraftment following injection have limited effective clinical translation. Though injectable biomaterials offer protection against membrane-damaging extensional flow and supply a supportive 3D environment in vivo that ultimately improves cell retention and therapeutic costs, most are created from synthetic or naturally harvested polymers that are immunogenic and/or chemically ill-defined. This work presents a shear-thinning and self-healing telechelic recombinant protein-based hydrogel designed around XTEN - a well-expressible, non-immunogenic, and intrinsically disordered polypeptide previously evolved as a genetically encoded alternative to PEGylation to "eXTENd" the in vivo half-life of fused protein therapeutics. By flanking XTEN with self-associating coil domains derived from cartilage oligomeric matrix protein, single-component physically crosslinked hydrogels exhibiting rapid shear thinning and self-healing through homopentameric coiled-coil bundling are formed. Individual and combined point mutations that variably stabilize coil association enables a straightforward method to genetically program material viscoelasticity and biodegradability. Finally, these materials protect and sustain viability of encapsulated human fibroblasts, hepatocytes, embryonic kidney (HEK), and embryonic stem-cell-derived cardiomyocytes (hESC-CMs) through culture, injection, and transcutaneous implantation in mice. These injectable XTEN-based hydrogels show promise for both in vitro cell culture and in vivo cell transplantation applications.


Sujet(s)
Matériaux biocompatibles , Hydrogels , Hydrogels/composition chimique , Humains , Matériaux biocompatibles/composition chimique , Thérapie cellulaire et tissulaire/méthodes , Élasticité , Animaux , Viscosité , Souris , Élastine/génétique , Élastine/composition chimique , Élastine/métabolisme
19.
J Dermatol ; 51(6): 816-826, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38470170

RÉSUMÉ

Ultraviolet (UV)-induced skin photoaging is caused by qualitative and quantitative degradation of dermal extracellular matrix components such as collagen and elastic fibers. Elastic fibers are important for maintaining cutaneous elasticity, despite their small amount in the skin. Previously, microfibril-associated protein 4 (MFAP-4), which is downregulated in photoaging dermis, has been found to be essential for elastic fiber formation by interaction with both fibrillin-1 and elastin, which are core components of elastic fiber. In addition, enhanced cutaneous MFAP-4 expression in a human skin-xenografted murine photoaging model protects against UV-induced photodamage accompanied by the prevention of elastic fiber degradation and aggravated elasticity. We therefore hypothesized that the upregulation of MFAP-4 in dermal fibroblasts may more efficiently accelerate elastic fiber formation. We screened botanical extracts for MFAP-4 expression-promoting activity in normal human dermal fibroblasts (NHDFs). We found that rosemary extract markedly promotes early microfibril formation and mature elastic fiber formation along with a significant upregulation of not only MFAP-4 but also fibrillin-1 and elastin in NHDFs. Furthermore, rosmarinic acid, which is abundant in rosemary extract, accelerated elastic fiber formation via upregulation of transforming growth factor ß-1. This was achieved by the induction of cAMP response element-binding protein phosphorylation, demonstrating that rosmarinic acid represents one of the active ingredients in rosemary extract. Based on the findings in this study, we conclude that rosemary extract and rosmarinic acid represent promising materials that exert a preventive or ameliorative effect on skin photoaging by accelerating elastic fiber formation.


Sujet(s)
Cinnamates , Depsides , Tissu élastique , Élastine , Fibrilline-1 , Fibroblastes , Extraits de plantes , , Vieillissement de la peau , Humains , Fibroblastes/effets des médicaments et des substances chimiques , Fibroblastes/métabolisme , Fibroblastes/effets des radiations , Depsides/pharmacologie , Fibrilline-1/métabolisme , Cinnamates/pharmacologie , Extraits de plantes/pharmacologie , Élastine/métabolisme , Tissu élastique/effets des médicaments et des substances chimiques , Tissu élastique/métabolisme , Vieillissement de la peau/effets des médicaments et des substances chimiques , Vieillissement de la peau/effets des radiations , Cellules cultivées , Rosmarinus/composition chimique , Régulation positive/effets des médicaments et des substances chimiques , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Peau/effets des médicaments et des substances chimiques , Peau/effets des radiations , Peau/cytologie , Peau/anatomopathologie , Peau/métabolisme , Derme/cytologie , Derme/effets des médicaments et des substances chimiques , Derme/métabolisme , Rayons ultraviolets/effets indésirables , Protéines de la matrice extracellulaire/métabolisme , Adipokines
20.
J Cosmet Dermatol ; 23(5): 1620-1628, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38468421

RÉSUMÉ

BACKGROUND: Skin's exposure to intrinsic and extrinsic factors causes age-related changes, leading to a lower amount of dermal collagen and elastin. AIM: This study investigated the effects of a novel facial muscle stimulation technology combined with radiofrequency (RF) heating on dermal collagen and elastin content for the treatment of facial wrinkles and skin laxity. METHODS: The active group subjects (N = 6) received four 20-min facial treatments with simultaneous RF and facial muscle stimulation, once weekly. The control subject (N = 1) was untreated. Skin biopsies obtained at baseline, 1-month and 3-month follow-up were evaluated histologically to determine collagen and elastin fibers content. A group of independent aestheticians evaluated facial skin appearance and wrinkle severity. Patient safety was followed. RESULTS: In the active group, collagen-occupied area reached 11.91 ± 1.80 × 106 µm2 (+25.32%, p < 0.05) and 12.35 ± 1.44 × 105 µm2 (+30.00%, p < 0.05) at 1-month and 3-month follow-up visits. Elastin-occupied area at 1-month and 3-month follow-up was 1.64 ± 0.14 × 105 µm2 (+67.23%, p < 0.05), and 1.99 ± 0.21 × 105 µm2 (+102.80%, p < 0.05). In the control group, there was no significant difference (p > 0.05) in collagen and elastin fibers. Active group wrinkle scores decreased from 5 (moderate, class II) to 3 (mild, class I). All subjects, except the control, improved in appearance posttreatment. No adverse events or side effects occurred. CONCLUSION: Decreased dermal collagen and elastin levels contributes to a gradual decline in skin elasticity, leading to facial wrinkles and unfirm skin. Study results showed noticeable improvement in facial appearance and increased dermal collagen and elastin content subsequent to simultaneous, noninvasive RF, and facial muscle stimulation treatments.


Sujet(s)
Collagène , Élastine , Muscles de la face , Vieillissement de la peau , Humains , Élastine/analyse , Élastine/métabolisme , Vieillissement de la peau/effets des radiations , Collagène/métabolisme , Collagène/analyse , Femelle , Adulte d'âge moyen , Adulte , Muscles de la face/effets des radiations , Traitement par radiofréquence/méthodes , Traitement par radiofréquence/effets indésirables , Mâle , Électrothérapie/effets indésirables , Électrothérapie/instrumentation , Électrothérapie/méthodes , Techniques cosmétiques/effets indésirables , Techniques cosmétiques/instrumentation , Peau/effets des radiations , Peau/anatomopathologie , Face , Biopsie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...